Mount Carmel recently released an "investigation timeline" purportedly detailing what they have learned about Dr. William Husel's role in prescribing excessive and potentially fatal doses of Fentanyl.
We recently obtained a copy of Mount Carmel's "Plan of Correction," which details, among other things, the following information:
Invokana belongs to a relatively new class of type 2 diabetes drugs called SGLT-2 inhibitors, which helps remove excess blood sugar through urine. The FDA just recently required Invokana to include a warning about a high risk of foot and leg amputations in diabetic patients. This change in the required warning is the result of two clinical trials that concluded that leg and foot amputations occurred about twice as often in patients with type 2 diabetes treated with Invokana, which puts a great many diabetic patients using Invokana at risk.